News
Tariff situation remains fluid and dynamic and uncertainty in the dental industry remains high. Our long-term sales assumption relies on continued innovation from the firm—which allocates 4% of sales ...
1d
Zacks Investment Research on MSNReasons to Retain DENTSPLY SIRONA Stock in Your Portfolio NowDENTSPLY SIRONA XRAY is well-positioned for growth due to its new digital-implant work flow and continued focus on research ...
Dentsply Sirona (XRA) stock turns lower as Morgan Stanley downgrades to Equal Weight amid macro challenges, innovation concerns, and tariff risks. Read more here.
As previously reported, Morgan Stanley downgraded Dentsply Sirona (XRAY) to Equal Weight from Overweight with a price target of $14, down from ...
A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call. Dentsply Sirona is the world’s largest diversified manufacturer of ...
A proposed class-action lawsuit was recently filed against Dentsply Sirona and Byte, alleging breaches of contract and implied warranty, false advertising and deceptive practices. Eight notes on the ...
In 2022, Good Glamm announced the purchase of a partial stake in Sirona for Rs 100 crore. The all-cash deal had faced legal scrutiny after founders and investors of Sirona issued notices to Good Glamm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results